Ixazomib citrate, 99.89%
cas: 1239908-20-3 — see every product listed under this CAS number, including other names
Ixazomib citrate, 99.89% (CAS 1239908-20-3) is a chemical reagent available from Chemat. Available pack sizes: 10 mg, 50 mg, 5 mg, 100 mg, 10mM/1mL. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-10452-10 mg |
| cas | 1239908-20-3 |
| size | 10 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 10 mg | 491.52 Pln | |
| MedChemExpress | 50 mg | 909.48 Pln | |
| MedChemExpress | 5 mg | 384.71 Pln | |
| MedChemExpress | 100 mg | 1438.90 Pln | |
| MedChemExpress | 10mM/1mL | 421.86 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.89% |
Ixazomib citrate is a glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of 2,2'-{2-[(1R)-1-amino-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid. A prodrug for ixazomib that is used in combination therapy for treatment of multiple myeloma. It has a role as an antineoplastic agent, a prodrug, a proteasome inhibitor, an apoptosis inducer and an orphan drug. It is a member of benzamides, a dichlorobenzene, a glycine derivative, an oxo dicarboxylic acid and a 1,3,2-dioxaborolane. It is functionally related to an ixazomib.
Source: ChEBI
| Molecular formula | C20H23BCl2N2O9 |
|---|---|
| Molecular weight | 517.1 g/mol |
| IUPAC name | 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid |
| InChIKey | MBOMYENWWXQSNW-AWEZNQCLSA-N |
| SMILES | B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl |
Computed by PubChem (NCBI)